Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neurons
US10342851B2 · kind B2 · utility
0Cited by
2References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 16, 2018 |
| Grant date | Jul 9, 2019 |
| Priority date | — |
| Expiry date | Mar 16, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of an Engrailed protein as a medicament for increasing dopamine synthesis by dopaminergic neurons, in particular in the management of conditions associated with a decrease of dopamine levels without loss of dopaminergic neurons.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.